INSIGHTS ON CLINICAL TRIAL PARTNERING

• AI-Powered Strategy Is Redefining Patient Recruitment Performance

  This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

• How Sponsors, CROs, And Tech Vendors Can Reduce Site Tech Overload

  Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.

• Optimizing The Path From First-In-Human To Proof-Of-Concept

  By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

• How Do Site Payments Impact Clinical Trial Sustainability?

  Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

• Why AI Matters In Early Phase Clinical Trials

  3/11/2026

  AI speeds early‑phase development by streamlining data review, enabling structured queries, accelerating PK/PD work, and revealing biomarker patterns — boosting efficiency with expert oversight.

• The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials

  10/21/2025

  Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

• How RFI/RFP Optimization Changes The Game

  8/22/2025

  Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.

• Scaling Global Vaccine Mega-Trials For A Top Five Pharma

  4/16/2026

  See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.

• State of Materiovigilance: Gaps, Technology & Outsourcing

  5/12/2026

  Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.